Argenx
ARGX
#550
Rank
C$54.67 B
Marketcap
$914.36
Share price
0.90%
Change (1 day)
50.02%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : C$4.44 Billion

According to Argenx 's latest financial reports the company has C$4.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$2.97 B-0.1%
2021-12-31C$2.97 B-4.89%
2020-12-31C$3.13 B42.61%
2019-12-31C$2.19 B118.16%
2018-12-31C$1.00 B54.57%
2017-12-31C$0.65 B352.8%
2016-12-31C$0.14 B104.87%
2015-12-31C$70.18 M-26.93%
2014-12-31C$96.06 M103.8%
2013-12-31C$47.13 M64.42%
2012-12-31C$28.66 M-28.88%
2011-12-31C$40.31 M188.71%
2010-12-31C$13.96 M